Ftse Mib
33.235,42
-0,24%
DAX
18.067,91
-0,31%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
64.827,90
-0,48%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Y mAbs Therapeutics Inc (YMAB) Y mAbs Therapeutics Inc (YMAB) Notizie

Y mAbs Therapeutics Inc

YMAB
11,91
0,16 (1,36%)
19 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/6/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202422:05EDGAR2Form 8-K - Current report
12/6/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202401:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:59EDGAR2Form 144 - Report of proposed sale of securities
10/6/202422:44EDGAR2Form 144 - Report of proposed sale of securities
07/6/202413:05GLOBEY-mAbs Announces Preclinical GD2-SADA Data to be Presented..
05/6/202413:05GLOBEY-mAbs Deepens Radiopharmaceutical Leadership with..
01/6/202414:15GLOBEY-mAbs Announces Publication of Preclinical GD2-SADA Data at..
01/6/202414:05GLOBEY-mAbs Announces New Interim Analysis of Phase 2 Data for..
01/6/202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202422:42EDGAR2Form 144 - Report of proposed sale of securities
07/5/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:10EDGAR2Form 8-K - Current report
07/5/202422:05GLOBEY-mAbs Reports First Quarter 2024 Financial Results and..
26/4/202413:05GLOBEY-mAbs to Announce First Quarter 2024 Financial and..
25/4/202422:05GLOBEY-mAbs to Present at 2024 ASCO Annual Meeting
14/3/202414:05GLOBEY-mAbs Therapeutics Announces Resignation of Chief Financial..
07/3/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:49EDGAR2Form 144 - Report of proposed sale of securities
06/3/202422:40EDGAR2Form 144 - Report of proposed sale of securities
06/3/202401:05EDGAR2Form 144 - Report of proposed sale of securities
04/3/202413:30GLOBEY-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to..
04/3/202412:05EDGAR2Form 8-K - Current report
29/2/202423:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202422:05GLOBEY-mAbs Reports Fourth Quarter and Full Year 2023 Financial..
29/2/202422:04EDGAR2Form 8-K - Current report
16/2/202413:30GLOBEY-mAbs to Announce Fourth Quarter and Full Year 2023..
14/2/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202421:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202423:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202412:45EDGAR2Form 8-K - Current report
02/1/202422:05GLOBEY-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan..
26/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202301:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:40EDGAR2Form 144 - Report of proposed sale of securities
13/12/202322:05GLOBEY-mAbs Therapeutics Added to the NASDAQ Biotechnology Index
12/12/202314:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202314:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 11,78 Min: 11,58 Max: 12,00
Chiusura: 11,75

La tua Cronologia

NASDAQ
YMAB
Y mAbs Therapeutics
ASX
IVVSOG
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network